問卷

TPIDB > Principal Investigator

Principal Investigator


Kuang Tien General Hospital (在職)

Division of Infectious Disease

Division of Thoracic Medicine

更新時間:2023-09-19

潘信宏
  • Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

5Cases

2024-12-01 - 2025-11-30

Phase III

Completed
A Phase 3, Randomized, Observer‑blind, Active‑control Study to Evaluate the Immunogenicity, Reactogenicity, and Safety of mRNA‑1083 (SARS‑CoV‑2 and Influenza) Vaccine in Healthy Adults ≥50 Years of Age
  • Condition/Disease

    SARS‑CoV‑2 and Influenza

  • Test Drug

    injection

Participate Sites
8Sites

Recruiting8Sites

2007-11-15 - 2008-06-30

Phase II

  • Condition/Disease

  • Test Drug

Participate Sites
24Sites

Terminated23Sites

Study ended1Sites

2008-12-01 - 2009-06-30

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
19Sites

Terminated19Sites

2010-06-30 - 2015-03-31

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
11Sites

Terminated11Sites

2008-09-01 - 2009-06-30

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
14Sites

Terminated14Sites